Fenwick represented Belharra Therapeutics on the deal.Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with Genentech,…
Belharra Therapeutics’ Multi-year Collaboration with Genentech
